PharmaPendium. The definitive source of best-in-class drug information



Similar documents
Discover more, discover faster. High performance, flexible NLP-based text mining for life sciences

We use Reaxys intensively for hit identification, hit-to-lead and lead optimization.

Not All Clinical Trials Are Created Equal Understanding the Different Phases

THOMSON REUTERS CORTELLIS FOR INFORMATICS. REUTERS/ Aly Song

GE Healthcare. Perfect match. Centricity Group Management and Centricity EMR

Careers in Biostatistics and Clinical SAS Programming An Overview for the Uninitiated Justina M. Flavin, Independent Consultant, San Diego, CA

Why Are Drugs So Expensive? Learning About the Drug Development Process

ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals. Step 5

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. Current Step 4 version

Pharmacology skills for drug discovery. Why is pharmacology important?

Boost the Success of Medical Device Development With Systematic Literature Reviews

CTC Technology Readiness Levels

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S1A. Current Step 4 version

Guideline for Industry

A leader in the development and application of information technology to prevent and treat disease.

Market Access for Medical Technology & Pharmaceutical Companies An Organizational Priority in Times of Economic Austerity and Reform

Achieving Regulatory Success: Areas of focus for biotechnology companies. Michael J. Schlosser, PhD, DABT April 21, 2013

THE BIOTECH & PHARMACEUTICAL INDUSTRY

CTD Dossier Preparation. Sr.Manager-Regulatory Affairs

Chemical safety and big data: the industry s demands

Driving Innovation in Licensing Through Competitive Intelligence and Big Data Analytics

CLINICAL DEVELOPMENT OPTIMIZATION

Importing pharmaceutical products to China

The Clinical Trials Process an educated patient s guide

Research on Research: Learning about Phase 1 Trials

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more:

PharmD Postdoctoral Fellowship Program

TIBCO Spotfire Helps Organon Bridge the Data Gap Between Basic Research and Clinical Trials

Overview of CDISC Implementation at PMDA. Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA)

Quality by Design Concept

Guidance for Industry

Sheffield Kidney Institute. Planning a Clinical Trial

Overview of Drug Development: the Regulatory Process

NEW CHEMICAL ENTITIES

Empowering Global Medical Information Teams with Software Solutions

Roche Position on Human Stem Cells

Practice profitability

Strategic Consulting Services

LexisNexis CourtLink Best Practice Guide

Certified National Pharmaceutical Representative

Elsevier ClinicalKey TM FAQs

Normand Laberge Vice-President Regulatory & Scientific Affairs Rx&D. Globalization of Clinical Research: Trends & Implications for Canada

Principles for Responsible Clinical Trial Data Sharing

Regulatory Pathways for Licensure and Use of Ebola Virus Vaccines During the Current Outbreak FDA Perspective

From Data to Foresight:

Find the signal in the noise

QLIKVIEW FOR LIFE SCIENCES. Partnering for Innovation and Sustainable Growth

Product Information YOUR BUSINESS OPERATING SYSTEM

Bringing Order to Your Clinical Data Making it Manageable and Meaningful

Integrated Clinical Data with Oracle Life Sciences Applications. An Oracle White Paper October 2006

Use of MedDRA in CTCAE and in the Biopharmaceutical Industry

Medical Device Solutions. Battelle. Applied Research Device Development Clinical Research Sustaining Engineering

LEVERAGING OPEN SOURCE INTELLIGENCE (OSINT) TO COMBAT FRAUD

Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies

Clinical Trial Trends Outline Complexity for Supply Chain. Scott Ohanesian, VP Commercial Operations APAC

Pharmaceutical Sciences

MSc in Toxicology. Master Degree Programme

CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD

Sample-Global Big Data Market in the Healthcare Sector. technavio insights

SAFETY PHARMACOLOGY STUDIES FOR HUMAN PHARMACEUTICALS S7A

Apply with Resume to: Submenu Path Company/Careers/Current Openings/Job Type: Science

Drug Development Process

Thermo Scientific Compound Discoverer Software. A New Generation. of integrated solutions for small molecule structure ID

Goals & Objectives. Drug Development & the FDA Pharmacy 309. Outline. An History of Disasters. Be able to describe

U.S. Food and Drug Administration Center for Devices and Radiological Health REGULATORY SCIENCE PRIORITIES (FY2016)

ABSTRACT INTRODUCTION PATIENT PROFILES SESUG Paper PH-07

Valuation of Your Early Drug Candidate. By Linda Pullan, Ph.D. Toll-free USA Worldwide

Glossary of Clinical Trial Terms

exactly. The need for efficiency in developing effective new therapeutics has never been greater.

KNOWLEDGENT WHITE PAPER. Big Data Enabling Better Pharmacovigilance

Bio-IT World 2013 Best Practices Awards

The Management of Pharmaceuticals in the Environment (PIE) FAQ. Key questions and answers. Q: How do pharmaceuticals get into the environment?

Medicine Safety Glossary

Introduction to pharmaceutical technology

Adopting Site Quality Management to Optimize Risk-Based Monitoring

is a knowledge based expert decision support tool for predicting the metabolic fate of chemicals in mammals.

Leveraging innovative security solutions for government. Helping to protect government IT infrastructure, meet compliance demands and reduce costs

Managing and Integrating Clinical Trial Data: A Challenge for Pharma and their CRO Partners

Ph.D Programs at Near East University Faculty of Pharmacy

Big Data and Text Mining

How To Use Data Analysis To Get More Information From A Computer Or Cell Phone To A Computer

Clinical Trials and Safety Surveillance of Drugs in Development

MSC IN MEDICINAL CHEMISTRY

eclinical Services Predictable Pricing Full Service EDC Phase I-IV Sophisticated Edit Checks Drug Supply Chain Forms Library Data Collection Services

ORACLE CLINICAL. Globalization. Flexibility. Efficiency. Competition ORACLE DATA SHEET OVERVIEW ROBUST CLINICAL DATA MANAGEMENT SOLUTION

An Introduction to Genomics and SAS Scientific Discovery Solutions

Transcription:

Please contact us for more information Americas E-Customer Service 360 Park Avenue South New York, NY 10010-1710 USA Tel: +1 888 615 4500 (+1 212 462 1978, if calling from outside the USA and Canada) Fax: +1 212 462 1974 Email: usinfo@pharmapendium.com Europe, Middle East and Africa E-Customer Service Theodor-Heuss-Allee 108 60486 Frankfurt/Main, Germany Tel: +49 69 5050 4268 Fax: +49 69 5050 4213 Email: nlinfo@pharmapendium.com Asia Pacific E-Customer Service 1-9-15 Higashi-Azabu Minato-ku, Tokyo 106-0044 Japan Tel: +81 3 5561 5034 Fax: +81 3 5561 5047 Email: jpinfo@pharmapendium.com The definitive source of integrated preclinical, clinical and post-marketing drug information for: Preclinical and Clinical Safety Assessment Toxicology, Adverse Events Delivery Pharmacokinetics, Exposure Data Efficacy Biomarkers, Experimental Design, Primary & Secondary Endpoints Regulatory Affairs Precedents from Entire Library of FDA Approval Documents PharmaPendium The definitive source of best-in-class drug information Save time and operational costs Gain actionable data Plan intelligently Act smartly PharmaPendium is a trademark of Elsevier Inc. RTECS is a registered trademark of the U.S. Public Health Service in the United States. MedDRA is a registered trademark of the International Federation of Pharmaceutical Manufacturers Associations in the United States. Separate license to MedDRA required. All other names are or may be trademarks or registered trademarks of their respective owners. *Separate license to MedDRA required. pp_br_1108

Insightful Content Plus Powerful Functionality Now you can search, view and compare documents from the world s two major regulatory agencies the FDA & EMEA at the same time, on a single site, with a single search. PharmaPendium enables pharmaceutical researchers in preclinical and clinical drug development to finally be able to... PharmaPendium meets the critical needs of a variety of users within the biopharmaceutical industry including: Preclinical Safety Assessment Teams Toxicologists Pharmacokineticists Safety Pharmacologists Regulatory Affairs Staff Pharmacoepidemiologists Clinical Researchers Information Specialists Save valuable time PharmaPendium saves weeks to months typically spent during the drug development process on finding drug safety and approval data through document delivery services or the FDA. PharmaPendium provides searchable access to more than 850,000 pages of safety information in seconds so there is no need to spend weeks reading and skimming to find comparable data for safety profiles (animal, human and post-marketing data) for drugs similar to your candidate. Reduce strategic or opportunity costs PharmaPendium gives you a clear strategic advantage by providing new (mostly unpublished) relevant comparative data before making a decision or assessment. Avoid the submission mistakes made by competitors: Eliminate the risk of repeating costly regulatory cycles by searching historic FDA approval documents for previously unacceptable submissions. Save the cost of re-submission and the opportunity cost on your patent. Compare preclinical and clinical safety data of approved drugs to better predict animal model to human translation from the toxicity/adverse effect perspective. Reduce drug development cost by identifying safety risks earlier. Learn from approved drugs by viewing their integrated post-marketing safety data with toxicity/adverse effect data obtained in preclinical and clinical studies. Avoid re-inventing the wheel Using the globally-searchable PharmaPendium, researchers can find and cite previously run preclinical experiments they did not know even existed, possibly eliminating the need for planned studies that would have taken years to accomplish. Leverage the best historic data in a meaningful way PharmaPendium makes the entire FDA library of Freedom of Information (FOI) documents on the approval of drugs and their efficacy, safety, pharmacokinetics and pharmacodynamics detailed experimental data searchable and accessible for the first time. Prevent repeating the mistakes of the past PharmaPendium is the best tool available to avoid Regulatory Recycling by carefully examining data, statistics and experimental designs that were rejected in the past within your Drug Class or by your Reviewer. Respond quickly under pressure (the urgency factor) Have searchable documents at your fingertips in minutes when, for example, you are responding to FDA inquiries. When your patent clock is ticking, response time and fast access to precedents are critical. the only integrated and text-searchable source of FDA (back to first approved drug) and EMEA documents Pharmacokinetics Researchers: Make sure you have the Complete Picture PharmaPendium contains volumes of preclinical AND clinical exposure data at all parameters (cmax, tmax, AUC,Vss, CL, etc.) and all study groups (Healthy, Disease state, Concomitant Drugs) the vast majority of which are not published in the literature and so available nowhere else. This level of detail now available to drug delivery experts as a means of comparison or to draw inferences is a true breakthrough.

Best-in-Class, Trusted Content Sources Extracted data sets and the only product to provide longitudinal data views PharmaPendium provides access via a single point to searchable and trusted drug safety information covering over 3,000 approved drugs, with integrated preclinical, clinical and post-marketing safety data. US FDA Drug Approval Package Database (Reviews: post 1991) New! FDA Classic Collection all FDA drug approval documents on all drugs from 1992 back to the first approval files The combination of these two databases creates an entire searchable library of documents written by the FDA on the approval of drugs, pharmacokinetics, efficacy and safety New! European Medicines Agency (EMEA) European Public Assessment Reports (EPAR) Approval Documents Database (Drugs or indications approved in Europe with manually extracted preclinical, clinical toxicity and adverse effects data contains drugs not approved in the US) Meyler s Side Effects of Drugs, 15th edition Adverse Event Reporting System (AERS) Database Target information and target-drug relationships from multiple sources The PharmaPendium Drug Safety Database -- Pre-clinical and clinical toxicity data manually extracted from all FDA Approval Packages Toxicity information for approved drugs extracted from literature Metabolite and metabolic transformation information for PharmaPendium drugs extracted from literature Intuitive user interface with searchable access to all content Searchable FDA Drug Approval Document Usability and Efficiency That Simplify Research PharmaPendium is designed to help you develop safer drugs with increased efficiency, reduced risks and lowered cost. Dynamic interface streamlines the research process Previously FDA Freedom of Information documents and EMEA EPARs were only available in unsearchable formats like microfiche (order paper copy from FDA FOI), paper or a static PDF containing an unsearchable image. Now PharmaPendium finally solves this problem by delivering fully searchable, electronic FDA and EMEA documents. All FDA and EMEA documents on PharmaPendium are globally searchable and filterable by: Effect Targets Drugs Drug Classes Chemistry Sophisticated functionality saves you time PharmaPendium users have discovered that tasks that used to take several people weeks or even months are now easily done in minutes. Customizable searching yields results that help you make the right decisions Perhaps even more importantly, PharmaPendium allows such research and searches to find key decision-support information that would previously have been missed. Preclinical and clinical assessments and prioritization can now be done with the full complement of comparable data. Our features enable you to: Conduct research using four pathway options: drug class, adverse effects/toxicity, targets, and chemical compound Search using standardized terminology Medical Dictionary for Regulatory Activities (MedDRA *) Search text by keyword Filter search results by drugs/drug classes, adverse effects/toxicity, data sources, and/or other criteria Search by molecular structure or substructure and export results Gain searchable access to relevant sections within an FDA package by document type Export valuable safety information

Preclinical/Clinical Development Assessment Which competitors drugs have the same combination of adverse effects as my drug candidate? Show me the relevant preclinical and clinical studies. Show all antipsychotics that have exhibited Electrocardiogram (ECG) anomalies in preclinical experiments, clinical trials or post-marketing reports. Pharmacokinetics/Drug Delivery Assessment Find preclinical and clinical pharmacokinetics exposure parameters for the drugs in my drug class (Cmax, Tmax,Vss, etc.). See screenshot below.

Regulatory Affairs What can I learn from the history of regulatory cycling within my drug class in order to make this New Drug Application (NDA) proceed more quickly to approval? Searching on DNDP s requests (Division of Neuropharmacological Drug Products). Clinical Development What are the primary and secondary endpoints that have been described, used and approved within my drug class? See screenshot below.

Timely, trusted content combined with powerful functionality The only searchable database of ALL FDA Drug Approval Packages Important content beyond FDA documents now including EMEA EPAR Approval Documents Relevant information with an intuitive user interface and search tools that allow researchers to identify and collect the right information quickly Built for efficiency data sets, data views, and other features that enhance research productivity and yield results in minutes rather than days Stay on the safe side Identify safety risks earlier Reduce the drag of non-returning investments Make better predictions on animal model to human translation Use toxicity studies on excipients already reported by others Make the correct pipeline prioritization decisions Use precedents to make the best regulatory argument as quickly as possible Avoid regulatory recycling Discover the PharmaPendium advantage at info.pharmapendium.com IP licensing Web seminars Interactive video demonstrations Visit our website today